Skip to product information
1 of 1

LumiraDx Inc Antigen Test Control Kit LumiraDx™ SARS-CoV-2 Ag Positive Level / Negative Level 4 X 0.5 mL - Each - L016080109002-EA

LumiraDx Inc Antigen Test Control Kit LumiraDx™ SARS-CoV-2 Ag Positive Level / Negative Level 4 X 0.5 mL - Each - L016080109002-EA

Regular price $166.99
Sale price $166.99 Regular price
OFF Sold out
Shipping calculated at checkout.

50 In stock

Estimated deliver:

Flat-Rate Shipping from $8.25

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details
Reviews

LumiraDx Inc Antigen Test Control Kit LumiraDx™ SARS-CoV-2 Ag Positive Level / Negative Level 4 X...

Item Id 1197712
MF Id# L016080109002
Brand LumiraDx™
Manufacturer LumiraDx Inc
Country of Origin Unknown
Application Control Kit
Container Type Vial
For Use With For use in Conjunction with the LumiraDx SARS-CoV-2 Ag Test Strip System on the LumiraDx Instrument
Form Liquid
Levels Positive Level / Negative Level
Product Dating McKesson Acceptable Dating: we will ship >= 30 days
Storage Requirements Requires Refrigeration
Test Name SARS-CoV-2 Ag
Test Type Antigen Test
UNSPSC Code 41116128
Volume 4 X 0.5 mL

Features

  • The LumiraDx SARS-CoV-2 Ag Test is for use under an Emergency Use Authorization ONLY: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
  • Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C 263a, that meet the requirements to perform moderate, high or waived complexity tests
  • This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
  • The LumiraDx SARS-CoV-2 Ag test does not differentiate between SARS-CoV and SARS-CoV-2
  • Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status; positive results do not rule out bacterial infection or co-infection with other viruses
  • Negative results, from patients with symptoms onset beyond twelve days, should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed
  • Negative results do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
  • The LumiraDx SARS-CoV-2 Ag Quality Controls (hereafter referred to as Quality Controls) are liquid quality controls to be used with the LumiraDx Instrument (hereafter referred to as the Instrument) and the LumiraDx SARS-CoV-2 Ag Test (hereafter referred to as SARS-CoV-2 Ag Test)
  • The LumiraDx SARS-CoV-2 Quality Controls are intended for liquid quality control testing performed on the LumiraDx Instrument when used with the LumiraDx SARS-CoV-2 Ag Test Strip
  • The LumiraDx SARS-CoV-2 Ag Test is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings, and proficient in performing tests using the LumiraDx Instrument This test is o
  • Kit contents: 2 X 0.5ml vial SARS-CoV-2 Ag Positive Control, 2 X 0.5ml vial SARS-CoV-2 Ag Negative Control, 24 Transfer pipettes (20 µl), LumiraDx SARS-CoV-2 Ag Quality Control Pack Insert
  • Requires: LumiraDx Instrument, LumiraDx SARS-CoV-2 Ag Test Strips, and LumiraDx Connect– if connectivity required (refer to LumiraDx Connect User Manual)
About your query!
Recently Viewed